Nanoform
Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing attrition in clinical trials and on enhancing drug molecules’ formulation performance through its nanoforming services. Nanoform’s capabilities include GMP manufacturing and span the small to large molecule development space. The company focuses on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications.
Trending Articles
Upcoming event
Related Content
Drug Delivery
Nanoformed TargTex oncology drug candidate TTX101 receives FDA Orphan Drug Designation
Nanoform Finland Plc (Nasdaq Helsinki NANOFH; Nasdaq Stockholm NANOFS), an innovative nanoparticle medicine enabling company, announced its customer TargTex S.A. has been granted Orphan Drug Designation by the FDA for its nanoformed drug candidate TTX101 to be used in patients with malignant gliomas